Analysis identifies no-response advanced nasopharyngeal carcinoma using quantitative synthetic MRI parameters, suggesting future treatment pathways.
Motivation: About 10%~30% of advanced nasopharyngeal carcinoma (ANPC) remained residual and relapse after chemoradiotherapy (CRT), so it would be valuable to pretreatment prediction of no-response ANPC. Goal(s): Quantitative syMRI parameters for predicting no-response ANPC before CRT. Approach: 95 response and 32 no-response ANPC were enrolled, and the T1, T2, PD values from syMRI and clinicopathological characteristics were compared. Logistic regression was used to construct prediction model. Results: T1, T2, PD values were significantly lower in no-response ANPC. The combination of T1, T2, PD can achieve good prediction performance (AUC=0.897). The syMRI combined with clinicopathological characteristics can improve prediction performance (AUC=0.974). Impact: Our study suggested syMRI can non-invasively identify no-response ANPC patients before CRT. Therefore, the application of syMRI would be beneficial for treatment selection and management of ANPC patients.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: